BR112012025654A2 - seleção e uso de células hospedeiras para produção de glicoproteína - Google Patents

seleção e uso de células hospedeiras para produção de glicoproteína

Info

Publication number
BR112012025654A2
BR112012025654A2 BR112012025654A BR112012025654A BR112012025654A2 BR 112012025654 A2 BR112012025654 A2 BR 112012025654A2 BR 112012025654 A BR112012025654 A BR 112012025654A BR 112012025654 A BR112012025654 A BR 112012025654A BR 112012025654 A2 BR112012025654 A2 BR 112012025654A2
Authority
BR
Brazil
Prior art keywords
selection
host cells
electron beam
glycoprotein production
microfocus
Prior art date
Application number
BR112012025654A
Other languages
English (en)
Inventor
E Collins Brian
J Bosques Carlos
Venkataram Ganesh
Duffner Jay
Thiruneelakantapillai Lakshmanan
Bhatnagar Naveen
Farutin Victor
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Publication of BR112012025654A2 publication Critical patent/BR112012025654A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • X-Ray Techniques (AREA)

Abstract

elemento de catálogo para um tubo de raios-x microfoco. um elemento de catálogo para um tubo de raios-x microfoco compreende um filamento que consiste de fio aquecível para emissão termiônica de elétrons para formar um feixe de elétrons. o filamento compreende em uma região de fonte do feixe de elétrons uma extensão alongada (11, 12) em cada uma das duas direções perpendiculares ao feixo de elétrons.
BR112012025654A 2010-04-07 2011-04-07 seleção e uso de células hospedeiras para produção de glicoproteína BR112012025654A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32186310P 2010-04-07 2010-04-07
PCT/US2011/031641 WO2011127325A1 (en) 2010-04-07 2011-04-07 Selection and use of host cells for production of glycoproteins

Publications (1)

Publication Number Publication Date
BR112012025654A2 true BR112012025654A2 (pt) 2017-07-18

Family

ID=44763294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012025654A BR112012025654A2 (pt) 2010-04-07 2011-04-07 seleção e uso de células hospedeiras para produção de glicoproteína

Country Status (8)

Country Link
US (1) US20130123126A1 (pt)
EP (1) EP2555801A4 (pt)
CN (1) CN102917733A (pt)
AU (1) AU2011237445B2 (pt)
BR (1) BR112012025654A2 (pt)
CA (1) CA2794709A1 (pt)
MX (1) MX2012011647A (pt)
WO (1) WO2011127325A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2602108T3 (es) 2010-04-07 2017-02-17 Momenta Pharmaceuticals, Inc. Método para cuantificar glicoformas que contienen alta manosa
CN103782168B (zh) 2011-03-12 2016-03-16 动量制药公司 在糖蛋白产品中包含n-乙酰己糖胺的n-聚醣
WO2013181576A2 (en) * 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods of evaluating and making biologics
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
US20150125848A1 (en) * 2012-06-01 2015-05-07 Momenta Pharmaceuticals, Inc. Methods related to alemtuzumab
WO2014149067A1 (en) 2013-03-15 2014-09-25 Momenta Pharmaceuticals, Inc. Methods related to ctla4-fc fusion proteins
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
CA2936831A1 (en) * 2014-01-13 2015-07-16 Sergey SHULGA-MORSKOY Method for optimizing post-translational modifications on recombinant proteins
US11719704B2 (en) 2015-12-30 2023-08-08 Momenta Pharmaceuticals, Inc. Methods related to biologics
JP7415771B2 (ja) * 2020-04-24 2024-01-17 株式会社島津製作所 分析支援装置、分析支援方法および分析支援プログラム
CN111518825B (zh) * 2020-04-30 2022-10-11 浙江工业大学 一种多基因组合表达制备蛹虫草多糖的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047335A (en) * 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
CN1314913A (zh) * 1998-06-10 2001-09-26 格里科设计公司 有针对性的组合化合物库及其进行筛选所用的高效测定方法
US6949372B2 (en) * 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
CA2459040A1 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
ATE430580T1 (de) * 2001-10-25 2009-05-15 Genentech Inc Glycoprotein-zusammensetzungen
MXPA05010773A (es) * 2003-04-09 2005-12-12 Neose Technologies Inc Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos.
US20060127950A1 (en) * 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
US20060252672A1 (en) * 2005-04-05 2006-11-09 Betenbaugh Michael J Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation
CA2682578C (en) * 2007-04-03 2015-05-26 Oxyrane Uk Limited Glycosylation of molecules
EP2528002B1 (en) * 2007-04-16 2015-11-04 Momenta Pharmaceuticals, Inc. Defined glycoprotein products and related methods
WO2008128230A1 (en) * 2007-04-16 2008-10-23 Momenta Pharmaceuticals, Inc. Reference glycoprotein products and related methods
US8338088B2 (en) * 2007-04-16 2012-12-25 Momenta Pharmaceuticals, Inc. Methods related to cell surface glycosylation
US8084222B2 (en) * 2008-09-26 2011-12-27 Eureka Therapeutics, Inc. Methods for generating host cells

Also Published As

Publication number Publication date
EP2555801A1 (en) 2013-02-13
US20130123126A1 (en) 2013-05-16
AU2011237445B2 (en) 2016-03-24
CN102917733A (zh) 2013-02-06
EP2555801A4 (en) 2014-02-26
CA2794709A1 (en) 2011-10-13
MX2012011647A (es) 2012-11-29
WO2011127325A1 (en) 2011-10-13
AU2011237445A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
BR112012025654A2 (pt) seleção e uso de células hospedeiras para produção de glicoproteína
EP3168856A3 (en) X-ray sources using linear accumulation
EP4295970A3 (en) X-ray device and structure manufacturing method
BR112014019198A8 (pt) Sistema de imagiologia de múltiplas vistas de transmissão e espalhamento combinado
IL241897A (en) Pro-electric emitter for electron beam emission and radiation production
BR112013031049A2 (pt) tubo de raios x para gerar radiação de raios x, sistema de obtenção de imagem por raios x, método para gerar um feixe de raios x de múltipla energia, uso de uma unidade de filtro para a geração da radiação de raios x de múltipla energia, elemento de programa de computador para controlar um aparelho e meio legível em computador
WO2014116665A3 (en) Directed x-ray fields for tomosynthesis
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
BR112017004114A2 (pt) torre de transmissão de energia
EP3479392A4 (en) HIGH BRIGHTNESS BORED ELECTRON BEAM EMITTERS FOR USE IN A VACUUM
EP3154433A4 (en) Radiography and computed tomography with high-energy electron beams
BR112018006103A2 (pt) aplicador de precisão
CL2016002794A1 (es) Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico
IL267375A (en) Electron beam emitters with ruthenium coating
EP2997612A4 (en) Actinic and electron beam radiation curable water based electrode binders and electrodes incorporating same
BR112012031770A2 (pt) pano não tecido reforçado
WO2012119009A3 (en) Electron beam source system and method
PE20161158A1 (es) Aparato y metodo de apoyo en tierra
BR112017002496A2 (pt) agente de controle contra a síndrome reprodutiva e respiratória porcina
BR112018003238A2 (pt) seleção de pacientes para terapia de combinação
BR112017006511A2 (pt) método para produção de uma manta de espuma
EP3033761A4 (en) Dual tube support for electron emitter
CY1122725T1 (el) Αποσμητικη συνθεση που περιλαμβανει ενα μειγμα αλφα, βητα και γαμμα κυκλοδεξτρινων
CL2016001627A1 (es) Polvo de carbón conductor, método para la fabricación del mismo y uso del mismo
BR112019005825A2 (pt) vírus envelopado modificado, composição farmacêutica, e, método para tratar um câncer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]